BOCA RATON, Fla., Feb. 27, 2017 /PRNewswire/ -- Cancer
Treatment Centers of America® (CTCA), in collaboration with
NantHealth and Allscripts, is implementing a custom technical
solution that, for the first time, enables eviti®, a NantHealth
clinical decision support solution, access to clinical workflows in
the Allscripts Sunrise electronic health record (EHR). With
seamless integration of this clinical decision support solution,
the Clinical Pathways program helps inform the cancer treatment
process, without interrupting the physician's clinical workflow.
The direct interface of the clinical operating system (NantOS) was
built with the input of hundreds of oncologists across the nation
and holds a comprehensive collection of evolving cancer care
data.
"Clinical Pathways presents all appropriate treatment options.
It also helps eliminate potential guesswork by clinicians routinely
inundated with new data and oncology research," said George Daneker, Jr., MD, Chief Medical Officer
at CTCA® at Southeastern Regional Medical Center. "We created an
ecosystem of treatment options, customized to the CTCA standard of
care, for patients to review and choose from that's safe and
efficient."
Designed with the patient in mind, Clinical Pathways integrates
the latest cancer research available, treatment regimens and
complementary therapies into the Allscripts Sunrise EHR, giving
oncologists the ability to create a curated list of care protocols
at the point of care. When the treatment platform is engaged it
provides:
- Custom treatment regimens specific to the patient, their health
and specific disease state
- Comparisons between treatment options, including average market
cost of delivery
- Computer order entry with the tap of the screen – safe for the
patient and efficient
- Each treatment regimen recommended by eviti is mapped within
the EHR to proprietary CTCA order sets that reflect an
integrative approach to care delivery, which combines
evidence-based clinical approaches with supportive therapies to
meet each patient's unique needs and optimize their quality of life
while undergoing cancer treatment
- Access to referenced up-to-date guidelines, response rates,
adverse drug reactions and toxicity
- Supporting clinical data
- Real-time functionality
Clinical Pathways creates greater transparency around
therapeutic selection and care delivery, and also helps to improve
quality and efficiency by reducing variability in care. With this
integrated platform, patients and their clinical teams can discuss
and compare treatment regimens, providing patients with greater
confidence of the appropriateness of their prescribed treatment for
their specific diagnosis. Clinical Pathways can also expedite
approval from insurance providers by effectively providing the
necessary clinical data to support selected treatment
strategies.
"Cancer Treatment Centers of America, Allscripts and NantHealth
began planning this project in early 2016 to help patients and
providers alike benefit from the clinical capabilities of an
integrated solution," said Paul
Black, Allscripts Chief Executive Officer. "Through a
careful analysis of clinical workflows and strategic design
sessions, we've delivered a solution that enhances and improves the
chemotherapy regimen selection and ordering process, and
ultimately, the quality of care CTCA provides to its patients."
The integration of the eviti solution with Allscripts Sunrise
EHR for Clinical Pathways allows physicians to retrieve information
from an unbiased Evidence-Based Medical Library, which encompasses
over 2,700 of the most appropriate, evidence-based treatment
regimens covering all cancers and cancer subtypes and all
modalities. The library is meticulously compiled from peer-reviewed
literature, oncology associations, and government agencies, and
maintained by a full-time team of oncologists and oncology nurses,
clinical informatics professionals, and an advisory board of
nationally recognized oncology experts. Each regimen incorporates
the level of evidence, expected clinical outcomes, treatment costs,
toxicities and supporting literature. Once a regimen is selected,
providers can launch directly into order entry through Allscripts'
unique open ability to integrate eviti regimens with Sunrise order
sets.
"The eviti solution plays an integral role in bringing together
the Clinical Pathways platform by allowing physicians access to
real-time evidence-based treatment regimens for all types of
cancer," said Bobby Reddy, Senior
Executive Director of Medical Affairs of NantHealth. "The
collective technology is proving to be a game changer for cancer
care – allowing communication with all key stakeholders to occur
more efficiently from prognosis to diagnosis to treatment. We're
pleased to support CTCA's Clinical Pathways platform with
NantHealth's eviti solution to advance cancer care and
treatment."
Clinical Pathways is available for use with every patient at all
five CTCA hospital locations.
About Cancer Treatment Centers of America®
Cancer
Treatment Centers of America Global, Inc. (CTCA), headquartered in
Boca Raton, Fla., is a national
network of five hospitals that serves adult patients who are
fighting cancer. CTCA® offers an integrative approach to care that
combines advancements in genomic testing and precision cancer
treatment, surgery, radiation, immunotherapy and chemotherapy, with
evidence-informed supportive therapies designed to help patients
physically and emotionally by enhancing their quality of life while
managing side effects both during and after treatment. CTCA serves
patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among
U.S. hospitals that deliver the highest quality of care and patient
experience, CTCA provides patients and their families with
comprehensive information about their treatment options and
encourages their active participation in treatment decisions. For
more information, visit cancercenter.com, Facebook.com/cancercenter
and Twitter.com/cancercenter.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader
in healthcare information technology solutions that advance
clinical, financial and operational results. Our innovative
solutions connect people, places and data across an Open, Connected
Community of Health™. Connectivity empowers caregivers to make
better decisions and deliver better care for healthier populations.
To learn more, visit www.allscripts.com, Twitter, YouTube and It
Takes A Community: The Allscripts Blog.
About NantHealth, Inc.
NantHealth, Inc., a member of
the NantWorks ecosystem of companies, is a next-generation,
evidence-based, personalized healthcare company enabling improved
patient outcomes and more effective treatment decisions for
critical illnesses. NantHealth's unique systems-based approach to
personalized healthcare applies novel diagnostics tailored to the
specific molecular profiles of patient tissues and integrates this
molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system, CLINICS, which includes its
unique software, middleware and hardware systems infrastructure
that collects, indexes, analyzes and interprets billions of
molecular, clinical, operational and financial data points derived
from novel and traditional sources, continuously improves
decision-making and further optimizes our clinical pathways and
decision algorithms over time. For more information please
visit www.nanthealth.com and follow Dr. Soon-Shiong
on Twitter @DrPatSoonShiong.
About eviti®
eviti® is a SaaS-based,
point-of-care clinical decision support platform that allows
oncologists to quickly see and assess treatment regimens, outcomes,
cost, and level of evidence in order to confidently select a
clinically-appropriate treatment. eviti consists of three
applications – eviti Advisor, eviti Advisor Enterprise, and eviti
Connect® – that together support advanced cancer care by
aligning the priorities of physicians, payors, and patients at the
moment of clinical prescribing.
Contact:
Abigail Obre
Abigail.Obre@ctca-hope.com
(561) 923-3198 (O)
(954) 551-0519 (C)
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cancer-treatment-centers-of-america-partners-with-allscripts-and-nanthealth-to-launch-clinical-pathways-a-comprehensive-and-custom-oncology-treatment-platform-300414105.html
SOURCE Cancer Treatment Centers of America